A Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis
Status:
Completed
Trial end date:
2016-11-30
Target enrollment:
Participant gender:
Summary
This is a single arm, multicenter, open-label, Phase 1b study to evaluate the safety and
tolerability of vismodegib in combination with pirfenidone in participants with idiopathic
pulmonary fibrosis (IPF) currently being treated with pirfenidone.